Clinical performance of the novel DiaSorin LIAISON® XL murex: HBsAg Quant, HCV-Ab, HIV-Ab/Ag assays

Journal of Clinical Virology

Volumn 59, Issue 1, 2014, Pages 44-49

  Krawczyk, Adalbert ^a   Hintze, Christian ^b   Ackermann, Jessica ^a   Goitowski, Birgit ^a   Trippler, Martin ^a   Grüner, Nico ^a   Neumann Fraune, Maria ^c   Verheyen, Jens ^a,c   Fiedler, Melanie ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Diasorin SpA   (Italy)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

HBsAg mutants; HBsAg quantification; HCV; HIV; LIAISON XL; Murex

Indexed keywords

ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; INTERFERON; TENOFOVIR;

ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; CONTROLLED STUDY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOASSAY ANALYZER; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; STANDARDIZATION; WORLD HEALTH ORGANIZATION;

AB; AG; ANTIBODY; ANTIGEN; CHEMILUMINESCENCE IMMUNOASSAY; CLIA; ENTECAVIR; ETV; HBSAG; HBSAG MUTANTS; HBSAG QUANTIFICATION; HBV; HCV; HEPATITIS B VIRUS; HEPATITIS B VIRUS SURFACE ANTIGEN; HEPATITIS C VIRUS; HIV; HUMAN IMMUNODEFICIENCY VIRUS; IFN; INTERFERON; LIAISON(®) XL; MUREX; S/CO; SIGNAL-TO-CUTOFF-RATIO; TDF; TENOFOVIR;

AUTOMATION, LABORATORY; CLINICAL LABORATORY TECHNIQUES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV ANTIBODIES; HIV ANTIGENS; HIV INFECTIONS; HUMANS; IMMUNOASSAY;

EID: 84891833542     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.10.009     Document Type: Article

References (23)

1. WHO Hepatitis B fact sheet no. 204 2012, Available at: http://wwwwhoint/mediacentre/factsheets/fs204/en/.
2. WHO Hepatitis C fact sheet no. 164 2012, Available at: http://wwwwhoint/mediacentre/factsheets/fs164/en/.
3. WHO Human immundeficiency virus fact sheet no 360 2012, Available at: http://wwwwhoint/mediacentre/factsheets/fs360/en/indexhtml.
4. Thierfelder W., Hellenbrand W., Meisel H., Schreier E., Dortschy R. Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998. European Journal of Epidemiology 2001, 17:429-435.
5. Abteilung für Infektionsepidemiologie des RKI F. Zum Welt AIDS Tag. Epidemiol Bull 2012;47.
6. Servant-Delmas A., Mercier M., El Ghouzzi M.H., Girault A., Bouchardeau F., Pillonel J., et al. National survey of hepatitis B virus (HBV) polymorphism in asymptomatic HBV blood donors from 1999 to 2007 in France. Transfusion 2010, 50:2607-2618.
7. Geretti A.M., Patel M., Sarfo F.S., Chadwick D., Verheyen J., Fraune M., et al. Detection of highly prevalent hepatitis B virus coinfection among HIV-seropositive persons in Ghana. Journal of Clinical Microbiology 2010, 48:3223-3230.
8. Verheyen J., Neumann-Fraune M., Berg T., Kaiser R., Obermeier M. The detection of HBsAg mutants expressed in vitro using two different quantitative HBsAg assays. Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2012, 54:279-281.
9. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. Journal of Hepatology 2012, 57:167-185.
10. EASL clinical practice guidelines: management of hepatitis C virus infection. Journal of Hepatology 2011, 55:245-264.
11. Ross R.S., Viazov S., Wolters B., Roggendorf M. Towards a better resolution of hepatitis C virus variants: CLIP sequencing of an HCV core fragment and automated assignment of genotypes and subtypes. Journal of Virological Methods 2008, 148:25-33.
12. Esteban J.I., van Helden J., Alborino F., Burgisser P., Cellerai C., Pantaleo G., et al. Multicenter evaluation of the elecsys(R) anti-HCV II assay for the diagnosis of hepatitis C virus infection. Journal of Medical Virology 2013, 85:1362-1368.
13. Kim S., Kim J.H., Yoon S., Park Y.H., Kim H.S. Clinical performance evaluation of four automated chemiluminescence immunoassays for hepatitis C virus antibody detection. Journal of Clinical Microbiology 2008, 46:3919-3923.
14. Miedouge M., Greze M., Bailly A., Izopet J. Analytical sensitivity of four HIV combined antigen/antibody assays using the p24 WHO standard. Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2011, 50:57-60.
15. Tuaillon E., Mondain A.M., Nagot N., Ottomani L., Kania D., Nogue E., et al. Comparison of serum HBsAg quantitation by four immunoassays, and relationships of HBsAg level with HBV replication and HBV genotypes. PloS ONE 2012, 7:e32143.
16. Sonneveld M.J., Rijckborst V., Boucher C.A., Zwang L., Beersma M.F., Hansen B.E., et al. A comparison of two assays for quantification of Hepatitis B surface antigen in patients with chronic hepatitis B. Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2011, 51:175-178.
17. Popp C., Krams D., Beckert C., Buenning C., Queiros L., Piro L., et al. HBsAg blood screening and diagnosis: performance evaluation of the ARCHITECT HBsAg qualitative and ARCHITECT HBsAg qualitative confirmatory assays. Diagnostic Microbiology and Infectious Disease 2011, 70:479-485.
18. Weber B., Orazi B., Raineri A., Thorstensson R., Burgisser P., Muhlbacher A., et al. Multicenter evaluation of a new 4th generation HIV screening assay Elecsys HIV combi. Clinical Laboratory 2006, 52:463-473.
19. Kinn S., Akhavan S., Agut H., Thibault V. Performance of the DiaSorin LIAISON((R)) anti-HBs II for the detection of hepatitis B surface antibodies: comparison with the Abbott Architect anti-HBs assay. Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2011, 50:297-302.
20. Sillanpaa M., Melen K., Porkka P., Fagerlund R., Nevalainen K., Lappalainen M., et al. Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection. Virology Journal 2009, 6:84.
21. Jonas G., Pelzer C., Beckert C., Hausmann M., Kapprell H.P. Performance characteristics of the ARCHITECT anti-HCV assay. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 2005, 34:97-103.
22. Hnatyszyn H.J. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antiviral Therapy 2005, 10:1-11.
23. Dhaliwal S.K., Prescott L.E., Dow B.C., Davidson F., Brown H., Yap P.L., et al. Influence of viraemia and genotype upon serological reactivity in screening assays for antibody to hepatitis C virus. Journal of Medical Virology 1996, 48:184-190.